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Thyroid hormone, or T3, is essential in many bodily functions, from early 
development to the maintenance of health in adults. It is crucial for growth and skeletal 
development, development of the nervous system, cell differentiation, and maintenance 
of metabolic balance. The thyroid hormone receptor, TR, is a major mediator of thyroid 
hormone action. TR is a transcription factor and able to activate or repress transcription 
depending on the binding of its ligand, T3. There are two isoforms of TR, encoded by 
different genes: TRα and TRβ. Each of these isoforms have multiple alternative splicing 
products.  
While TR’s main function is carried out in the nucleus, multiple studies have 
shown that TR is shuttled rapidly between the nucleus and cytosol. Mislocalization of TR 
can be linked to diseases such as T3 resistance and cancer. Nuclear localization is 
mediated by importins, which bind to TRα by recognizing nuclear localization signals 
(NLSs).  
Previous studies have shown the presence of two NLS in the TRα1 isoform: in the 
Hinge domain (NLS 1) and in the A/B transactivation domain (NLS 2). NLS 1 is a 
classical, bipartite NLS and is also present in the TRβ1 isoform. NLS2 is a conserved, 
monopartite NLS that is only present in the TRα1 isoform. It has been previously 
demonstrated that both NLS are individually capable of directing GFP-GST-GFP (G3)-
tagged domain constructs to the nucleus, though NLS-2 is less efficient.  
These same G3 domain constructs were used to investigate binding of importin 
α1, β1, and 7 to both TRα1 NLS. GFP-Trap co-immunoprecipitation (Chromo-Tek) and 
immunoblotting techniques, we have demonstrated that the importin α1/β1 heterodimer 
interacts with both the A/B and Hinge domains, while Importin 7 interacts only with the 
A/B domain. This is consistent with our findings that IPO 7 does not interact with TRβ1, 
which lacks NLS2.This, along with knockdown experiments, indicate that nuclear import 
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Thyroid hormone receptors, or TRs, mediate action of thyroid hormone in the 
cell. These receptors act as transcription factors that modulate gene expression in 
response to the presence of thyroid hormone. In order to carry out its function, TR must 
be transported into the nucleus after translation in the cytoplasm and bind to DNA. 
Additionally, while TR is primarily localized to the nucleus in a healthy cell, it has been 
shown to shuttle in and out of the nucleus rather than simply remain there (Bunn et al. 
2001; Mavinakere et al. 2012). Transport between the nucleus and cytoplasm is targeted 
by sequences of amino acids called nuclear localization sequences (NLSs) and nuclear 
export sequences (NESs), which mark molecules for nuclear import and export 
respectively. This transport is mediated by molecules collectively referred to as β-
karyopherins, or Kapβs. Kapβs bind to proteins at NLSs or NESs and direct them toward 
the nucleus. The purpose of this study was to explore the precise mechanisms of nuclear 
import of TR. 
Thyroid hormone 
The thyroid hormones, T3 and T4, are essential in many bodily processes, 
including neurological development and metabolic regulation. There are two main forms 
of thyroid hormone, thyroxine (T4) and triiodothyronine (T3). T3 is the active hormone, 
and T4 must be converted to T3 by deiodinases before acting on the cell (Chiamolera and 
Wondisford 2011; Zhang and Lazar 2000).  
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The hypothalamus secretes thyrotropin releasing hormone, or TRH, which 
stimulates the anterior pituitary to release thyroid-stimulating hormone (TSH). TSH in 
turn stimulates the thyroid gland to produce thyroid hormones T3 and T4. Levels of T3 
and T4 must be kept within a relatively narrow range, and this system, called the 
hypothalamus-pituitary-thyroid (HPT) axis, is tightly regulated by a negative feedback 
mechanism. Increased levels of T3 and T4 inhibit the production of TSH by the anterior 
pituitary as well as the production of TRH by the hypothalamus (Chiamolera and 
Wondisford 2011) (Fig. 1).  
Abnormally low levels of thyroid hormone, a physiological condition known as 
hypothyroidism, can lead to a variety of diseases and conditions. During fetal 
development, low levels of thyroid hormone in the mother can lead to mental retardation, 
cerebral spastic diplegia, and other conditions even in the absence of other symptoms of 
hypothyroidism. Hypothyroidism in neonates can lead to less severe mental retardation as 
well as growth retardation and speech deficits (Williams 2008). In adults, abnormal levels 
of hormone can lead to disorders of metabolism as well as neurological symptoms such 
as depression (Hage and Azar, 2012).  
It was previously believed that thyroid hormone could diffuse passively into the 
cell in a manner similar to steroid hormones. However, it has since become clear that 
transport of thyroid hormone into cells is facilitated by dedicated transport proteins. 
These thyroid hormone transporters, such as monocarboxylate transporter 8 (MCT8), are 
essential for proper function of thyroid hormone. Inactivating mutations of these transport 











Fig. 1. The hypothalamus-pituitary-thyroid (HPT) axis. Secretion of 
thyrotropin releasing hormone (TRH) by the hypothalamus stimulates the 
anterior pituitary to release thyroid stimulating hormone (TSH), which in 
turn simulates the thyroid to produce the thyroid hormones T4 and T3. T4 




Dudley syndrome (Brent 2012; Heuer and Visser 2009). Different transporters can 
preferentially transport T4 or T3 (Heuer and Visser 2009).   
Thyroid hormone receptor: mechanism of action 
 TR and gene expression 
Thyroid hormone affects gene expression through the thyroid hormone receptor, 
or TR. TR is encoded by two genes, TRHA and TRHB, which encode the α and β 
isoforms respectively. TR isoforms are expressed in different amounts in different 
tissues; TRα, the focus of this thesis, is expressed primarily in the brain, heart, and 
skeletal muscle (Brent 2012; Cheng et al. 2010). Differential splicing of each isoform 
results in a number of splicing variants: TRα1, TRα2, TRα3, TRβ1, TRβ2, and TRβ3. 
TRα2 and TRα3 are unable to bind T3, whereas all of the TRβ isoforms are capable of 
binding T3 and are expressed at different levels in different tissues (Brent 2012).  
TR is a nuclear receptor, part of a superfamily of transcription factors which 
control gene expression in response to binding of their cognate ligand. Within this 
superfamily are three types of receptors: type I, which bind ligand in the cytoplasm and 
are transported into the nucleus after ligand binding; type II, including TR, which are 
retained in the nucleus and bind DNA in both the presence and absence of ligand; and 
type III, which includes the “orphan receptors”. Type II receptors are capable of both 
activating gene transcription in the presence of ligand and repressing transcription in the 
absence of ligand, and so reside in the nucleus. “Orphan receptors” are receptors whose 
ligands are not known (McKenna and O’Malley 2002). TR is a type II receptor, and 
localizes to the nucleus and binds to DNA regardless of the presence of thyroid hormone.  
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TR acts by binding to DNA at TREs, or thyroid hormone response elements. 
When ligand is absent, TR generally silences gene transcription; when ligand is bound, it 
induces a conformational change that promotes gene expression. Most TR functions as a 
heterodimer with the RXR, though homodimers and monomers are also able to bind 
DNA (Zhang and Lazar 2000). Both TR’s activating and repressive functions are 
physiologically important; elimination of TR altogether results in different phenotypes 
than depletion of T3 in mice. Additionally, in some species, TR is expressed in early 
development before production of thyroid hormone begins. These factors indicate that 
TR’s actions in the absence of ligand – i.e., suppression of certain genes – are 
physiologically relevant in addition to its positive regulation functions (Bernal and Morte 
2013).  
Mutations in TR have been linked to diseases such as resistance to thyroid 
hormone (RTH) and cancers. Resistance to thyroid hormone, due to dominant-negative 
mutations in TRβ is best characterized. Until recently, RTH was thought to only emerge 
from mutations to TRβ and TRα mutations were thought to be lethal (Brent, 2012; 
Espiard et al. 2015; Ortiga-Carvalho et al. 2014). RTH due to TRβ mutations can result in 
many different phenotypes; symptoms are more severe in individuals who are 
homozygous for a dominant-negative mutation. These symptoms include goiter, learning 
disability, delays in growth and development, and hearing deficits (Brent 2012). RTH due 
to dominant-negative mutations in TRα can result in delays in bone development, short 
stature, and cognitive impairment (Brent 2012; Espiard et al. 2015; Ortiga-Carvalho et al. 




TR and functional domains 
TR, like all nuclear receptors, is comprised of four functional domains: the N-
terminal A/B domain (also called the AF1 domain), the DNA binding domain (DBD), the 
Hinge domain, and the ligand binding domain (LBD) (Fig. 2). While the DBD, Hinge 
domain, and LBD are similar across nuclear receptors and between TR isoforms, the A/B 
domain remains variable. The region C-terminal to the LBD also shows variability across 
receptors (Mavinakere et al. 2012). Each domain has an individual function and is 
capable of acting outside of the context of the entire protein or when inserted into another 
protein (Zhang and Lazar, 2000).  
The A/B domain, also called the AF1 domain, is important in activating gene 
transcription. This domain is also where the structure of TRα and TRβ differ the most 
(Brent 2012). Isoform-specific actions of TR are likely due to variations in this region, 
including the higher potency of TRα (Hollenberg et al. 1995). In TRα, the A/B domain 
contains a nuclear localization signal (NLS-2) that is absent in TRβ (Mavinakere et al. 
2015). The DBD, which contains two zinc finger motifs, recognizes TREs on DNA and 
directly interacts with these elements; this domain is highly conserved across nuclear 
receptors (Cheng et al. 2010; Brent 2012; Zhang and Lazar, 2000). The Hinge domain 
connects the DBD and LBD. It also contains a nuclear localization signal, designated 
NLS-1; this localization signal is present in both TRα and TRβ (Mavinakere et al. 2012).  
The LBD is the largest single domain in TR. In the absence of the receptor’s 
ligand, T3, the LBD is involved in the recruitment of corepressors which silence gene 
expression. Upon T3 binding to the LBD, the receptor undergoes a conformational 
change which results in recruitment of coactivators, leading to an increase in gene 
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transcription. This means that TR has a dual role as both an activator and repressor of 
transcription, and both roles have been shown to be important in development (Brent 
2012; Zhang and Lazar 2000; Bernal and Morte 2013). It has been shown in some cases 
that TR can activate gene expression in the absence of T3 and repress transcription upon 
ligand binding, but generally ligand binding is necessary for gene activation. The LBD is 
also involved in formation of heterodimers with other nuclear receptors including RXR. 
The LBD is truncated in TRα2, an alternative splicing product of the TRα gene. Unable 
to bind ligand, TRα2 acts as a dominant-negative repressor of gene transcription (Zhang 
and Lazar 2000; Brent 2012).  
Nucleocytoplasmic transport, intracellular localization, and TR function 
Overview of nuclear import and export 
Proper cell function is dependent on efficient, selective shuttling of molecules 
between cellular compartments. The ability of molecules to travel into and out of the 
nucleus is particularly essential: RNA transcripts of genes must be transported out of the 
nucleus for translation, and translated proteins that function in the nucleus must be 
A/BD DBD Hinge LBD 
Fig. 2: Schematic diagram of domains of TRα1. Localization signals are 
labeled; export sequences are omitted. Specific locations of NLS: NLS-1 
stretches from residues 130-147, in the Hinge region. NLS-2 stretches 




transported into it. Nuclear pore complexes (NPCs) are large, multiprotein structures 
embedded in the nuclear membrane and act as selective gates through which proteins can 
be translocated. The NPC is made up of approximately 30 proteins called nucleoporins. 
Small proteins (less than ~40 kDa) can diffuse passively through the complex; however, 
larger proteins must be transported actively into the nucleus (Marfori et al. 2010).  
Transport into and out of the nucleus is facilitated by a family of proteins called 
karyopherin β proteins, or Kapβs (Cook et al. 2007; Chook and Suel 2010). There are 
over 20 human Kapβ proteins known (Cook et al. 2007; Chook and Suel 2010). This 
family can be divided into importins and exportins, which, as their names imply, regulate 
nuclear import and export respectively. These molecules regulate transport of protein 
cargo by recognizing nuclear localization signals (NLSs, for import) and nuclear export 
signals (NESs, for export) on target molecules. After binding their cargo, the 
importin:cargo complex then docks at the NPC by interacting with special nucleoporins 
lining the inside of the nuclear pore, which contain series of highly disordered 
phenylalanine-guanine (FG) repeats (Cook et al. 2007; Marfori et al. 2010; Chook and 
Suel, 2010). Cargo and importin/exportin are then translocated across the nuclear 
membrane in a process that takes milliseconds (Grunwald and Singer 2012) (See Fig. 3).  
Association and disassociation of cargo and importin/exportin is controlled by 
Ran. (See Fig. 3). Ran is a small G protein that varies between a GTP and GDP bound 
state; Ran-GDP is incapable of binding Kapβ proteins. For import, association between 
importin and cargo occurs in the cytoplasm, with no Ran bound. Upon entry into the 
nucleus, Ran-GTP binds to importin and cargo dissociates. For export, cargo binds to 


















Fig 3. Schematic of the classical nuclear transport pathway. The NLS on 
cargo protein binds to the binding grooves of importin α. The importin 
β binding domain then binds to the concave surface of importin β (here 
represented as an arc, though the binding actually occurs at the concave 
surface of the superhelix). Importin β then interacts with the NPC, 
facilitating transport across the nuclear envelope. Ran-GTP binding 





and cargo, Ran-GDP, and the exportin dissociate (Cook et al. 2007; Chook and Suel, 
2010).   
Structure and function of the NPC 
As described above, the nuclear pore complex is a large, supramolecular structure 
of about 30 different proteins. The NPC is assembled around a central pore with a 
diameter of 30-40 nm (Lemke 2016). It includes two coaxial rings, one each on the 
nuclear and cytoplasmic faces of the membrane, which form a channel. Cytoplasmic 
filaments are anchored to the central ring on the cytoplasmic side, while the nuclear side 
includes a distal ring that provides anchoring sites for a nuclear basket extending into the 
nucleus (Stoffler et al. 2003; Hoelz et al. 2011). The channel is filled with proteins called 
FG-nucleoporins, so named because they are rich in phenylalanine-glycine residues. The 
FG repeats of the nuclear pore are highly disordered and form a permeability barrier 
within the central channel (Grunwald and Singer, 2012; Lemke 2016). This makes them 
difficult to study, as their structure and interactions can change under a variety of 
conditions (Lemke 2016). 
While the precise mechanism of translocation across the membrane has not been 
confirmed, there are several models to explain the selectivity and speed of transport. In 
general, models suggest that FG repeats form a physical barrier that prevents nonspecific 
entry or that interaction between the FG repeats and import/export complexes causes 
structural or chemical changes of the FG repeats. These include the “entropic exclusion” 
model, in which selectivity is achieved based on the volume occupied by FG repeats; the 
“entropic brush” model, in which interaction with import/export factors causes collapse 
of the FG repeats and allows cargo to go through the channel; models in which 
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interaction with transport factors causes polymerization of FG repeats, forming a 
“selective gel phase”; and a slide-and-exchange model in which FG repeatedly transitions 
between strongly and weakly interacting with import/export factors, and displacement of 
FG repeats by competing repeats while in the weakly interacting state (Grunwald and 
Singer 2012; Raveh et al. 2016). This causes cargo to “slide” through the NPC channel. It 
may be true that multiple models are used or contribute to nucleocytoplasmic transport, 
though certain modes would be more common than others (Raveh et al. 2016). 
Control of nuclear transport: rate and specificity 
Rates of nuclear import or export are regulated by a variety of mechanisms. 
Several of these involve increasing or lowering the affinity of NLSs or NESs to bind to 
importins or exportins. This can be achieved by post-translationally modifying these 
sequences or the protein itself, such as by phosphorylation (Christie et al. 2015). Other 
modes of regulation involve masking the NLS or NES so Kapβ proteins cannot bind 
(Christie et al. 2015). Conformational changes in cargo proteins can reveal or hide NLSs 
or NESs. Rate of import can also be regulated by modifying importins, rather than cargo; 
for example, acetylation of importin α in the importin β binding domain (see “The 
Classical Nuclear Import Pathway”) increases its affinity for importin β1 in vitro 
(Christie et al. 2015).  
Different Kapβ factors can recognize and transport different cargo. Many 
different NLSs and NESs have been discovered and characterized, and many different 
nuclear import and export pathways have been characterized as well (Mavinakere et al. 
2012; Cook et al. 2007; Chook and Suel, 2010). Dysfunction of import or export 
pathways can have physiological effects. Exportins are necessary for the nuclear export 
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of mRNA and thus protein expression (Cook et al. 2007). In the yeast Saccharomyces 
cerevisiae, the importin β homolog Kap95p has been shown to be important in cell cycle 
progression (Christie et al. 2015). In mouse, importin-13 is important in the progression 
of meiosis (Kimura and Imamoto 2014). Nuclear import and export are essential to the 
function of many biomolecules.   
As described above, TR functions in the nucleus by binding to DNA; however, it 
must be imported into the nucleus after being translated in the cytosol. Additionally, 
though TR functions by binding to DNA in the nucleus, previous research has shown that 
the receptor actually shuttles rapidly between the nucleus and cytoplasm (Bunn et al. 
2001; Grespin et al. 2008). That is, though TR overall localizes to the nucleus and has 
NLSs directing that localization, it also includes NESs and is exported out of the nucleus 
as well. As described above, TRα1 has been shown to have two NLSs, one each in the 
A/B domain and Hinge domain (Fig. 2). TRα1 also has at least 3 NESs located in the 
LBD (Mavinakere et al. 2012; Subramanian et al. 2015).  
 TR localization depends on a balance between nuclear import and export. The 
exact function of receptor shuttling is not clear, but may have to do with receptor 
turnover or with mediating crosstalk with other nuclear receptors (such as RXR) 
(Bonamy and Allison, 2006). Disruption of this balance could be linked to disease states 
such as cancer (Bonamy et al. 2005; DeLong et al. 2004; Bonamy and Allison 2006). The 
following is a review of common nuclear import pathways, with a focus on importins α, 
β1, and 7, as those have been shown to be involved in nuclear import of TRα1 (Roggero 




Nuclear localization signals (NLSs) 
The first nuclear localization signals (NLSs) were characterized in the 1980s, 
based on studies of the SV40 large T-antigen and Xenopus nucleoplasmin (Marfori et al. 
2010). These are considered classical NLSs, and utilize the classical nuclear import 
pathway (described in detail below). Classical nuclear localization signals can be 
monopartite or bipartite. Monopartite signals consist of a short cluster (3-5 residues) of 
basic amino acids. Bipartite signals also include that cluster of basic amino acids, but 
differ from monopartite NLSs in that they include an additional cluster of lysine and 
arginine residues about 10-12 amino acid residues away (Cook et al. 2007). There is 
some evidence that longer linker regions are also possible (Lange et al. 2010).  
Classical NLSs are recognized by importin α. They compete with the SV40 NLS 
for binding to importin α, because they utilize the same binding site(s) on importin α (see 
below, “The Classical Nuclear Import Pathway”). Other, non-classical NLSs have also 
been characterized. These can differ in the length of the sequence or in which importins 
recognize the sequence. NLS domains have also been observed that are much larger than 
classical NLSs and lack basic amino acids, such as the M9 NLS. In the cases of very 
large NLS domains, it is possible that the three-dimensional structure of the domain is 
crucial for proper function (Pemberton and Paschal 2005).  Additionally, importin α has 
also been shown to bind to non-classical NLSs, though at different locations on importin 





The classical nuclear import pathway 
In this pathway, importin α acts as an adaptor protein for importin β1 by binding 
to the NLS on the cargo protein. Importin β1 then binds to the importin β1 binding 
domain (IBB1) on importin α. Importin β1 then interacts with the NPC, and facilitates 
transport across the nuclear membrane. In some species, there are multiple variants of 
importin α, which can be specific for certain cargoes, but share similar structures and 
mechanisms of action (Christie et al. 2015). The focus of this thesis is on importin α1, as 
that has been implicated in TRα1 import (Roggero et al. 2016). 
Recognition and binding of classical NLS by importin α occurs at the inner 
surface of importin α, in the NLS binding domain. This domain is comprised of up to 10 
armadillo (ARM) repeats, each of which contains about 40 amino acids and forms three 
α-helices. These repeats then stack onto one another, resulting in a long, twisted molecule 
with inner concave and outer convex surfaces. NLSs bind to the inner concave surface, 
which includes two binding pockets of conserved tryptophan residues. These interact 
with the positively-charged residues of the NLS (Cook et al. 2007; Xu et al. 2010; 
Christie et al. 2015). The binding pockets form two binding sites, a major and minor site. 
Monopartite classical NLSs bind to the major site, while bipartite classical NLS bind to 
both the major or minor binding sites (each site interacting with one basic cluster in the 
bipartite signal). The linker region accounts for the distance between the two binding 
sites (Cook et al. 2007; Nakada et al. 2015) (Fig. 4).  
For transport to occur, importin β1 must bind to importin α. Importin β1 includes 




Fig 4. Structure of mouse importin α bound to nucleoplasmin, a classical 
bipartite NLS. Nucleoplasmin NLS is shown in orange. (Marfori et al. 
2012). PDB ID: 3UL1 
Fig 5. Structure of importin β bound to the IBB of importin α. (Cingolani 
et al. 1999). PBD ID: 1QGK 
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are so named because they were first discovered in the Huntingtin, elongation factor 3, 
PR65/A subunit of protein phosphatase 2A and the TOR lipid kinase. The repeats stack 
to form a superhelical structure; similarly to the importin α NLS-binding domain, this 
creates concave and convex surfaces. Cargo molecules, in this case importin α, bind to 
the concave surface of the superhelix (Cook et al. 2007; Cingolani et al. 2002; Marfori et 
al 2010). Importin β1 binds to the IBB domain of importin α by wrapping closely around 
it (Cook et al 2007; Marfari et al 2010; Xu et al. 2010; see Fig. 5). The convex surface of 
the superhelix then interacts with the FG-repeats of the NPC.  
Non-classical nuclear import pathways 
 Recognition of non-classical NLSs by importin α 
Importin α can also recognize non-classical NLSs. Some can bind directly to the 
minor binding site and do not use the major binding site, though these are rarer than 
classical NLSs (Nakada et al 2015, Chang et al 2013; Kosugi et al. 2008). Kosugi et al. 
(2008) described six classes of NLSs that interactwith importin α, two of which bound 
exclusively to the minor site. These classes of NLSs consist of a basic cluster followed by 
C-terminal hydrophobic amino acids (Christie et al. 2015).  
Recognition of cargo proteins by importin β1 alone 
Importin β1 can also bind to cargo directly, without the need for an adaptor. 
Proteins that are transported by importin β1 alone differ significantly from each other, 
and NLSs can vary in size and charge of residues (Marfori et al. 2010; Cingolani et al. 
2002). This is partially due to the large surface area of the protein and its flexible 
structure (Marfori et al. 2010). Several proteins, including parathyroid hormone related 
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protein (PTHrP) and the sterol-regulatory element binding protein 2 (SREBP-2), have 
been shown to be importin α independent and interact with importin beta1 (Cingolani et 
al. 2002).  PTHrP binds at a separate but overlapping cargo binding site from that which 
binds to the IBB domain of importin α (Cingolani et al 2002). Importin β1 must adopt a 
more open conformation to bind to SREBP-2, and binding relies on hydrophobic 
interactions rather than the electrostatic interactions necessary for IBB domain binding to 
importin β1 (Marfori et al. 2010).   
Importin 7 
Importin 7 can facilitate transport as a monomer or as heterodimer with importin 
β1. (Chook and Suel 2010, Roggero et al. 2016). Importin 7 is also involved in the 
transport of the glucocorticoid receptor (GR), another member of the nuclear receptor 
superfamily (Friedman and Yamamoto 2004). Generally, importin 7 appears to recognize 
a diverse array of localization sequences (Chook and Suel 2010). Molecules imported by 
importin 7 often can utilize other importins to enter the nucleus, including the α/β 
heterodimer pathway or importin β alone (Chook and Suel 2010).   
Nuclear import of thyroid hormone receptor α: thesis objective 
TRα1 has been demonstrated to have two NLSs: one classical, bipartite NLS 
located in the Hinge region, called NLS-1, and a novel, monopartite NLS in the A/B 
domain, called NLS-2 (Mavinakere et al. 2012; Fig. 2). The minimal amino acid 
sequence for NLS-1 is 130KRVAKRKLIEQNRERRRK147; the minimal amino acid 
sequence for NLS-1 is 22PDGKRKRK29 (Mavinakere et al. 2012). NLS-2 is absent in the 
TRβ1 isoform and is not active in TR’s oncogenic form, v-ErbA (Mavinakere et al. 
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2012). This may contribute the slightly greater cytoplasmic localization of TRβ and the 
cytoplasmic localization of v-ErbA (Mavinakere et al. 2012).  
NLS-2 has been shown to be necessary for efficient nuclear localization of TRα1. 
A mutation that disrupts NLS-2 results in less nuclear retention of TRα1, causing its 
localization to become more cytosolic (Mavinakere et al. 2012). Though NLS-1 in TRβ is 
sufficient to facilitate nuclear import, it is unable to fully compensate for the loss of NLS-
2 in TRα1 (Mavinakere et al. 2012). Additionally, amino acids flanking the minimal 
NLS-2 sequence can have profound effects on its efficiency (Mavinakere et al. 2012). In 
chicken TRα1, the first 11 N-terminal amino acids are necessary for complete nuclear 
localization; though these amino acids do not overlap directly with NLS-2, this 
demonstrates the importance of the A/B domain in directing nuclear localization of TRα1 
(Andersson and Vennström, 1997).  
Mislocalization of TR may be linked to oncogenic conversion of cells. v-ErbA, an 
oncogenic form of TR, has an inactive NLS-2 and an acquired viral nuclear export 
sequence (DeLong et al. 2005). v-ErbA maintains a significant cytosolic population in the 
cell (Bonamy and Allison 2006). v-ErbA dimerizes with TRα1 and RXR; this 
dimerization, combined with the cytosolic localization of v-ErbA, prevents a 
subpopulation of the receptors from entering the nucleus and results in a significant 
portion of endogenous receptor to remain the cytoplasm (Bonamy and Allison 2005).  
Knockdown of importins β1, 7, and α1 all result in decreased nuclear localization 
of TRα1. Inhibition of importin β1-mediated transport with importazole, a specific 
inhibitor of importin β1, also lead to a reduction in nuclear localization. This indicates 
that TRα1 uses these importins for nuclear import. Inhibition of importin β1 with 
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importazole also resulted in decreased nuclear localization of TRβ1; because TRβ1 and 
TRα1 share only the classical NLS in the Hinge region, this suggested that NLS-1 in the 
Hinge domain is involved in importin-β1 mediated transport (Roggero et al. 2016). 
Knockdown of other importins, including importins 4, 5, and 8, had no effect on nuclear 
localization of TRα1. Knockdown of variants of importin α (α2, α3, etc.) also had no 
effect on localization (Roggero et al. 2016). 
Importins β1, 7, and α1 have been shown to coimmunoprecipitate with GFP-
tagged TRα1 transfected into HeLa cells. This demonstrates that these importins interact 
with TRα1 either directly or as part of a complex (for example, the importin α/β1 
heterodimer) (Roggero et al. 2016). Importin 7 does not coimmunoprecipitate beyond 
background levels with TRβ1, suggesting that importin 7 does not interact with the Hinge 
domain NLS-1.  
 The main objective of this thesis research was to investigate importin binding to 
TRα1 NLSs, and specifically to determine if different importins interact specifically with 
either NLS. Fully understanding TR’s nuclear localization pathways is important in 
understanding TR’s overall mechanism of action. This thesis focuses on the nuclear 






See Appendix 1 for the composition of all mentioned reagents. 
Subcloning 
Initially, in order to investigate binding between TRα1’s nuclear localization 
signals and various importins, we attempted to generate His6 and GST (glutathione-S-
transferase; see glossary)-tagged constructs of each domain of TRα1, using the Gateway 
cloning system (Thermo Scientific).  
The Gateway cloning system uses site-specific recombination by topoisomerase I 
and involves cloning an insert into an entry vector before eventually cloning it into final 
expression vector (also called a “destination vector”). Individual domains and 
combinations of domains of TRα1 were amplified from rat TRα1 by PCR using specially 
designed primers. These primers contained sequences that would insure that the PCR 
product would be cloned into the entry vector in the correct orientation. The constructs 
were as follows: A/B domain, A/B-DBD, DBD alone, DBD-Hinge, Hinge alone, and 
LBD. After amplification by PCR, the inserts were cloned into the pENTR/D-TOPO 
vector by site-specific recombination. The insert was then cloned into a destination vector 
using the system’s LR Clonase Mix, which contains a mixture of integrase, integration 
host factor, and excisionase enzymes.   
These attempts were not successful, and resulted in no verifiable protein 
expression constructs. We found that the domains were never inserted into the entry 
vector or destination vector, or they could not be verified to be in the correct orientation 
in the destination vector. 
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We then attempted to generate clones using more traditional subcloning methods. 
We made use of GeneArt plasmids containing synthetic genes encoding the A/B domain, 
Hinge domain, and the full TRα1 (Life Technologies). Two expression vectors were 
used, the pGEX-6P2 (GE Healthcare) and the pQE-30 Xa (Qiagen) for the GST and His6 
tags respectively. Plasmids were sequentially digested using BamHI and SmaI restriction 
enzymes at appropriate temperatures; a variety of reaction times were attempted, ranging 
from 1 hour to over 5 hours. Between restriction digests, reactions were purified using the 
Qiagen PCR Purification Kit. After the second digest, samples were run on a 1% or 2% 
agarose gel according to size of the fragment of interest. Fragments were then excised 
from the gel and purified using Qiagen Gel Purification Kit.  
Several attempts at ligation reactions were made, experimenting with the relative 
ratios of insert to vector. Regardless of ratio, all reactions were ligated using New 
England Biolabs T4 ligase and incubated at 16 degrees Celsius for 12-16 hours. This 
resulted in some clones that could be verified by sequencing (His6-Hinge, His6-TRα). 
However, the clones have not yet been expressed in E. coli and several constructs have 
not yet been cloned. The other constructs have not yet been verified by sequencing.  
Immunoblotting 
Though these cloning efforts have been somewhat successful at generating tagged 
protein constructs, we decided to try another approach to investigate importin binding to 
TRα1. We used G3 (GFP-GST-GFP)-tagged protein constructs which had already been 
generated for a previous study (Mavinakere et al. 2012).  
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HeLa cells were seeded at 9 x 105 cells per plate in 100 mm culture plates with 
MEM (10% FBS). After 24 h, cells were transfected with 10 μg plasmid using 
Lipofectamine 2000 and incubated at 37˚C for 26 h. Cells were then washed with 
Dulbecco’s phosphate-buffered saline (D-PBS). Cells were treated with 0.7 mL 0.25% 
trypsin and collected with 1.0 mL MEM into 2.0 mL microcentrifuge tubes. Cells were 
then washed again with D-PBS, lysed with lysis buffer and protease inhibitor, and 
incubated on ice for 30 mins with mixing every 10 min.   
Samples were then centrifuged at 16,000 × g for 10 min and the supernatant 
transferred to a fresh 1.5 mL tube. After dilution with 0.3 mL of Dilution/Wash Buffer, 
GFP-Trap agarose beads (Chromo-Tek) were added to the sample after being equilibrated 
using Dilution/Wash Buffer. Samples were incubated for at least 2.5 h at 4˚C with 
constant inversion. Afterward, samples were centrifuged at 4˚C, 3,000 g, for 4 min. 
Samples of supernatant (unbound proteins) were taken and diluted in equal volume of 2x 
Sample Buffer. Beads were then washed 3-4 times with Dilution/Wash Buffer, and then 
were resuspended in 100 μL of 2x Sample Buffer.  
Samples of unbound and bound proteins were separated by 8% SDS-polyacrylamide 
gel electrophoresis and analyzed by immunoblotting. Accurate protein size was 
confirmed by comparison with pre-stained Kaleidoscope Protein Size Standards (Bio-
Rad). Antibodies used: anti-GFP (Santa Cruz), 1:2000; anti-IPOα1 (Abcam), 1:1000; 
anti-IPOβ1 (Santa Cruz) 1:1000; anti-IPO7 (Abcam), 1:1000; horseradish peroxidase 






Importin α1 and β1 interact with both NLS-1 and NLS-2 
 To determine interaction between importins and different NLSs, we made use of 
G3 (GST-GFP-GST)-tagged protein constructs of TRα1, A/B domain, and Hinge domain. 
Both G3-Hinge and G3-A/B have been shown to localize to the nucleus, though G3-A/B 
to a lesser degree. This may indicate that NLS-2 is less efficient at directing nuclear 
import out of context of the whole protein (Roggero et al. 2016; Mavinakere et al. 2012).   
 HeLa cells were transfected with the G3-constructs as well as empty G3 vector. 
Cells were then lysed and immunoprecipitated using GFP-Trap. Samples were analyzed 
via Western blot using GFP-specific antibodies to ensure successful transfection. Next, 
we sought to determine if endogenous importins were binding to the exogenous 
constructs. On separate blots, samples were analyzed using anti-importin α1 and β1 
antibodies (Fig 6 & 7). Results show that importin α1 and β1 were coimmunoprecipitated 
with G3-Hinge and G3-A/B, as well as full-length TRα1. This demonstrates that each 
NLS interacts with both of these importins.  
Importin 7 may interact with NLS-2, but direct interaction was not observed 
Western blots were also conducted using anti-importin 7 antibodies. No 
consistent, direct interaction between either NLS and importin 7 was observed (Fig. 8). 
This was puzzling, because importin 7 was shown to be involved in TRα1 transport, and 
to not bind to NLS-1 based on experiments with TRβ1 (Roggero et al. 2016). It may be 
possible that NLS-2 is not displayed properly or may be unable to bind to importin 7 out 
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of the context of the full-length protein. Further investigation will be necessary to 








Fig. 6. Binding of importin α1 to TRα1 domains. Blots were analyzed 
using anti-importin α1 antibodies (Abcam). Binding was observed 
between importin α1 and the Hinge and A/B domains. Empty G3 vector 
included as negative control. 







Fig. 7. Binding of importin β1 to TR α1 domains. Blots were analyzed 
using anti-importin β1 antibodies (Santa Cruz). Each lane indicates a 
separate experimental replicate. Binding was observed between 
importin β1 and the Hinge and A/B domains. Empty G3 vector 
included as negative control. 






Fig. 8. No consistent interaction between importin 7 and TRα1 
domains was observed. Interaction between either the A/B or Hinge 
domains and TRα1 was not shown above background levels. Blots 
were analyzed using anti-importin 7 antibodies (Abcam). G3 included 
as negative control. 
Exposure times: Unbound: 5s; Bound: 4 min 
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IV. Discussion & Future Directions 
 
This study, combined with past work, has shown that TRα1 utilizes multiple 
pathways to enter the nucleus. Direct interaction between both TRα1 NLS and importins 
α and β has been demonstrated, but further investigation is necessary to determine 
interaction between importin 7 and TRα1. More work is also necessary to determine if 
importin 7 is capable of transporting TRα alone or if it does so as part of a heterodimer 
with importin β. This work isf important in understanding the nature of TR shuttling 
between the nucleus and cytoplasm, which will help to understand the biological function 
and effects of receptor shuttling. 
Function of receptor shuttling 
 The exact purpose of receptor shuttling has not yet been fully explained. It is 
possible that shuttling out the nucleus is necessary for degradation and turnover of TR. It 
is also possible that shuttling contributes an additional level of transcriptional regulation 
by controlling the amount of TR in the nucleus at a given time. For example, v-ErbA, an 
oncogenic form of TRα, localizes to the cytosol and forms dimers with wild-type TRα. 
This dimerization may maintain a subpopulation of wild-type TRα in the cytoplasm, 
which would negatively impact TRα’s ability to regulate gene expression (Bonamy and 
Allison 2005). However, non-genomic actions of TRα or forms of TR have also been 
observed outside of the nucleus, and may begin to explain the function of TR shuttling 
and the role multiple TRα NLS play in TRα function. 
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A truncated form of TRα (TRΔα) is involved in mediating actin polymerization in 
the cytoplasm in response to T4 binding (Davis et al. 2016; Cheng et al. 2010). This form 
is comprised of only the C-terminal portion of the LBD and lacks any NLS (Davis et al. 
2014). p30-TRα, another truncated form of TRα transcribed from an internal state site, is 
located at the nuclear membrane, and is important in inducing cellular proliferation by 
interaction with signal transducing proteins upon T3 binding (Davis et al. 2015; 
Kalyanaraman et al. 2014). Truncated TRα is also involved with mediating T3 effects on 
MAPK and phosphatidylinositol-3-kinase (PI3K) mediated signaling in cells (Davis et al. 
2014; Kalyanaraman et al. 2014). A form of TRα lacking the A/B domain is found in the 
mitochondria and regulates T3-dependent gene expression there (Cheng et al. 2010). 
These functions, combined with the fact that TRα1 requires NLS-2 in the A/B domain for 
fully efficient nuclear transport (see introduction), indicates that NLS-2 could have an 
important role in controlling and targeting the action of TRα. 
Only truncated forms of TRα have been shown to have cytoplasmic or non-
nuclear function. Full-length TRα, though it shuttles between the nucleus and the 
cytoplasm, seems to function only in the nucleus (Cheng et al. 2010). Full-length TRβ, 
however, has been demonstrated to function in the cytoplasm (Cheng et al 2010; Martin 
et al. 2014). One such function is regulation of PI3K-mediated signaling. TRβ forms a 
cytoplasmic complex with PI3K, which dissociates upon addition of ligand, after which 
TRβ goes into the nucleus (Martin et al. 2014). 
   It is possible that cytoplasmic activity of full-length TRβ1 is related to the 
difference in localization between full-length TRβ and TRα, and for the additional NLS 
in TRα. Full-length TRβ maintains a larger cytoplasmic subpopulation in than full-length 
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TRα, indicating that NLS-2 may play an important role in efficient nuclear targeting of 
the receptor. This may be because full-length TRβ has important cytoplasmic functions, 
while only truncated forms of TRα (which may have altered or missing NLSs) have been 
demonstrated to act in the cytoplasm (Davis et al. 2014; Cheng et al. 2010; Martin et al. 
2014; Kalyanaraman et al. 2014; Lin et al. 2009).  
Significance of multiple import pathways and multiple NLSs 
 Many proteins, including other nuclear receptors, utilize multiple transport 
pathways (Friedman and Yamamoto, 2004; Christie et al. 2015). TRα’s use of multiple 
import pathways could serve a variety of functions. The glucocorticoid receptor (GR), for 
example, has been shown to interact with both importin 7 and the importin α/β 
heterodimer for nuclear import (Friedman and Yamamoto, 2004). The androgen receptor 
also uses multiple import pathways (Li et al. 2013).   
Proteins may utilize multiple import pathways to achieve finer control of nuclear 
import. For example, different pathways may be used at different times during the cell 
cycle, or under different conditions. Amounts of various import factors can vary between 
cell types (Kimura and Imamoto 2014). It is also possible for different NLSs to act in a 
cooperative manner, which is suggested by the fact that loss of one NLSs negatively 
affects TRα1’s import efficiency (Mavinakere et al. 2012). Proteins may also make use of 
multiple pathways in order to compensate should a pathway become inhibited or if a 
protein must compete with another protein for use of particular pathway. In all, the fact 
that TRα1 uses more than one import pathway is not unusual (Roggero et al. 2016).  
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Many of importin 7’s cargo proteins are also imported by another import 
pathway. The glucocorticoid receptor, as well as viral proteins such as HIV-1 Integrase, 
are imported by both importin 7 and the α/β1 heterodimer; further, HIV-1 integrase is 
imported both by importin 7 alone and by the importin 7/β1 heterodimer (Chook and Suel 
2011). TRα would be one of many proteins which use importin 7 in addition to other 
pathways for nuclear import. 
Future directions 
 Direct interaction between NLS-2 and TRα1 was not observed consistently. 
However, RNA knockdown experiments as well as in vitro import assays indicated that 
importin 7 was involved in TRα1 nuclear import. The fact that importin 7 was confirmed 
not to interact with NLS-1 in TRβ1 suggests that importin 7 would interact with NLS-2 
(Roggero et al. 2016). Further investigation is necessary to clarify this problem, and to 
determine how importin 7 may be involved with TRα1 nuclear import. Additional 
experiments to confirm direct interaction between importin 7 and NLS-2 of TRα1 are 
needed, possibly using different protein constructs to insure that the NLS is properly 
displayed to allow importin 7 binding. Amino acids that surround NLS-2 can greatly 
affect the efficiency of the NLS (Mavinakere et al. 2012). As such, these experiments 
could also make use of full-length TR with mutations in NLS-1 that prevent importin 
binding, in order to keep NLS-2 in the context of the entire protein. Additionally, it is 
necessary to explore whether importin 7 alone is sufficient for transport of TRα or if it 
acts as a heterodimer with importin β1. In vitro pull-down assays, rather than in vivo 
experiments, will also provide further insight into interactions between importins and TR.  
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V. Significance and Final Conclusions 
Understanding nuclear import and export of TRα is essential to understanding its 
overall function in a cell. TRα acts primarily as a transcription factor, and as such must 
enter the nucleus after translation in the cytoplasm. Nuclear retention of TRα is necessary 
for appropriate activation and repression of target genes (Cheng et al. 2010). Control of 
nuclear-cytoplasmic transport is therefore an important factor in the activity of TRα, as 
well as the activity of other nuclear receptors and proteins. 
Mislocalization of nuclear receptors has been linked to diseases including cancer. 
For example, a mutation common in prostate cancer leads to increased nuclear 
localization of the androgen receptor independent of ligand (Li et al. 2013).  In v-ErbA, 
an oncogenic form of TRα, acquisition of an additional NES on TRα causes it to remain 
cytosolic, and dimerization with wild-type TRα blocks its import into the nucleus 
(Bonamy and Allison 2005). Because of their role in control of gene expression, nuclear 
receptors in general are potential targets for drug therapies for cancers (Li et al. 2013; 
Bonamy and Allison 2005; Cheng et al. 2010). Fully understanding the mechanisms 
controlling TR localization will elucidate TR’s control over gene expression and 
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VII. Appendix I – Solutions and Reagents 
 
Dulbecco’s Phosphate-Buffered Saline (D-PBS) 
0.1 g KCl 
0.1 g KH2PO4 
4.00 g  NaCl 
1.08 g Na2HPO4 ∙ 7H2O 
Add dd H2O to 200 mL. Autoclave. Store at room temperature. 
 
Dilution/Wash Buffer (GFP-Trap) 
10 mM Tris-HCl, pH 7.5 
150 mM NaCl 
0.5 mM EDTA 
 
Lysis Buffer (GFP-Trap) 
10 mM Tris-HCl, pH 7.5 
150 mM NaCl 
0.5 mM EDTA 
0.5%  NP-40 
Store at 4 degrees C. Add appropriate volume of Halt 100x Protease Inhibitor Cocktail 
(Thermo Scientific) before use. 
 
2x SDS-PAGE Sample Buffer 
250 mM Tris-HCl, pH 6.8 
1-% Glycerol 
2% SDS 
0.01% Bromophenol blue 
20 mM DTT 
Add DTT immediately before use. 
 
